Alector Quarterly Balance Sheets Chart
Quarterly
|
Annual
Alector Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||
| current assets: | |||||||||||||||||||||||||||
| cash and cash equivalents | 44,771,000 | 37,973,000 | 33,021,000 | 37,159,000 | 47,545,000 | 72,552,000 | 74,555,000 | 101,964,000 | 131,540,000 | 195,555,000 | 154,323,000 | 184,231,000 | 172,265,000 | 454,620,000 | 329,152,000 | 516,532,000 | 125,713,000 | 110,703,000 | 49,969,000 | 84,979,000 | 92,501,000 | 160,917,000 | 89,641,000 | 86,974,000 | 69,208,000 | 60,954,000 | 65,470,000 |
| marketable securities | 262,509,000 | 316,578,000 | 380,376,000 | 420,043,000 | 455,789,000 | 489,531,000 | 474,306,000 | 486,897,000 | 498,508,000 | 473,774,000 | 558,528,000 | 574,075,000 | 636,590,000 | 413,951,000 | 406,099,000 | 261,318,000 | 193,857,000 | 252,041,000 | 363,339,000 | 376,735,000 | 411,139,000 | 387,618,000 | 263,432,000 | 294,472,000 | 341,725,000 | 375,641,000 | 224,938,000 |
| prepaid expenses and other current assets | 11,898,000 | 12,099,000 | 11,420,000 | 12,162,000 | 16,367,000 | 19,307,000 | 16,946,000 | 13,821,000 | 10,119,000 | 11,974,000 | 10,997,000 | 10,166,000 | 9,350,000 | 9,536,000 | 7,071,000 | 8,585,000 | 9,760,000 | 11,993,000 | 8,203,000 | 8,298,000 | 6,448,000 | 7,669,000 | 4,364,000 | 4,037,000 | 3,664,000 | 5,519,000 | 2,768,000 |
| total current assets | 319,178,000 | 366,650,000 | 424,817,000 | 469,364,000 | 519,701,000 | 581,390,000 | 565,807,000 | 613,147,000 | 647,992,000 | 686,002,000 | 726,435,000 | 774,963,000 | 827,021,000 | 890,926,000 | 749,713,000 | 788,019,000 | 329,330,000 | 374,737,000 | 421,511,000 | 470,012,000 | 510,088,000 | 556,204,000 | 357,437,000 | 385,483,000 | 414,597,000 | 442,114,000 | 293,176,000 |
| property and equipment | 13,914,000 | 16,207,000 | 17,145,000 | 18,216,000 | 19,950,000 | 20,835,000 | 21,861,000 | 23,115,000 | 24,289,000 | 24,998,000 | 25,521,000 | 26,289,000 | 26,034,000 | 26,228,000 | 27,330,000 | 27,898,000 | 28,701,000 | 29,469,000 | 30,181,000 | 30,583,000 | 31,516,000 | 32,670,000 | 33,852,000 | 33,861,000 | 32,014,000 | 21,733,000 | 10,937,000 |
| operating lease right-of-use assets | 16,990,000 | 19,082,000 | 19,951,000 | 20,809,000 | 23,417,000 | 24,321,000 | 25,195,000 | 26,039,000 | 26,302,000 | 27,066,000 | 27,811,000 | 28,530,000 | 29,226,000 | 29,899,000 | 30,569,000 | 31,121,000 | 31,617,000 | 32,094,000 | 32,470,000 | 27,304,000 | 27,868,000 | 28,179,000 | 28,476,000 | 28,765,000 | 29,058,000 | 30,665,000 | |
| restricted cash | 1,846,000 | 1,846,000 | 1,846,000 | 1,546,000 | 1,546,000 | 1,546,000 | 1,546,000 | 1,546,000 | 1,549,000 | 1,472,000 | 1,472,000 | 1,472,000 | 1,472,000 | 1,472,000 | 1,472,000 | 1,472,000 | 1,472,000 | 1,472,000 | 1,472,000 | 1,472,000 | 1,472,000 | 1,472,000 | 1,472,000 | 1,472,000 | 1,472,000 | 1,472,000 | 1,472,000 |
| other assets | 4,494,000 | 4,518,000 | 4,544,000 | 6,088,000 | 6,115,000 | 7,402,000 | 7,418,000 | 8,548,000 | 8,605,000 | 8,804,000 | 6,409,000 | 5,784,000 | 5,919,000 | 5,932,000 | 5,574,000 | 5,716,000 | 5,993,000 | 2,592,000 | 2,617,000 | 2,217,000 | 1,086,000 | 403,000 | 676,000 | 149,000 | 110,000 | 60,000 | 2,774,000 |
| total assets | 356,422,000 | 408,303,000 | 468,303,000 | 516,023,000 | 570,729,000 | 635,494,000 | 621,827,000 | 672,395,000 | 708,737,000 | 748,342,000 | 787,648,000 | 837,038,000 | 889,672,000 | 954,457,000 | 814,658,000 | 854,226,000 | 397,113,000 | 440,364,000 | 488,251,000 | 531,588,000 | 572,030,000 | 618,928,000 | 421,913,000 | 449,730,000 | 477,251,000 | 496,044,000 | 308,359,000 |
| liabilities and stockholders’ equity | |||||||||||||||||||||||||||
| current liabilities: | |||||||||||||||||||||||||||
| accounts payable | 2,217,000 | 2,326,000 | 2,215,000 | 5,017,000 | 4,375,000 | 4,586,000 | 3,775,000 | 4,679,000 | 4,667,000 | 3,126,000 | 4,189,000 | 4,546,000 | 4,646,000 | 6,752,000 | 4,749,000 | 2,341,000 | 11,942,000 | 5,310,000 | 3,004,000 | 1,370,000 | 4,760,000 | 4,039,000 | 278,000 | 258,000 | 540,000 | 1,200,000 | 126,000 |
| accrued clinical supply costs | 5,150,000 | 5,831,000 | 6,989,000 | 3,379,000 | 2,738,000 | 5,870,000 | 5,215,000 | 7,430,000 | 6,536,000 | 7,691,000 | 5,559,000 | 5,444,000 | 6,142,000 | 12,618,000 | 8,748,000 | 7,418,000 | 7,174,000 | 9,384,000 | 11,148,000 | 9,320,000 | 6,102,000 | 12,315,000 | 6,706,000 | 6,412,000 | 5,981,000 | 3,723,000 | 4,463,000 |
| accrued liabilities | 14,215,000 | 17,320,000 | 28,890,000 | 25,696,000 | 23,081,000 | 19,385,000 | 30,378,000 | 30,423,000 | 22,918,000 | 18,580,000 | 27,771,000 | 23,225,000 | 23,705,000 | 20,042,000 | 27,460,000 | 20,586,000 | 22,100,000 | 18,970,000 | 22,538,000 | 27,065,000 | 15,576,000 | 16,709,000 | 18,256,000 | 16,546,000 | 14,577,000 | 8,000,000 | 8,439,000 |
| deferred revenue, current portion | 13,402,000 | 21,850,000 | 23,663,000 | 55,427,000 | 63,961,000 | 73,352,000 | 82,975,000 | 80,561,000 | 68,550,000 | 61,773,000 | 48,231,000 | 119,684,000 | 106,994,000 | 95,611,000 | 90,803,000 | 94,683,000 | 25,417,000 | 22,700,000 | 23,886,000 | 26,596,000 | 32,739,000 | 32,089,000 | 30,165,000 | 29,527,000 | 40,871,000 | 38,526,000 | 34,905,000 |
| payable to collaboration partner | 6,607,000 | 9,045,000 | 5,914,000 | 6,772,000 | 5,813,000 | 15,632,000 | 7,703,000 | ||||||||||||||||||||
| refund liability to collaboration partner, current portion | 33,859,000 | 44,571,000 | 48,634,000 | 37,554,000 | 39,107,000 | 37,557,000 | 39,440,000 | 23,919,000 | 21,400,000 | ||||||||||||||||||
| operating lease liabilities, current portion | 8,904,000 | 8,830,000 | 8,754,000 | 8,680,000 | 8,607,000 | 8,535,000 | 8,462,000 | 8,390,000 | 8,199,000 | 8,130,000 | 8,059,000 | 7,990,000 | 7,922,000 | 7,855,000 | 7,795,000 | 7,787,000 | 7,760,000 | 7,698,000 | 7,512,000 | 6,736,000 | 6,679,000 | 6,623,000 | 6,565,000 | 5,975,000 | 5,133,000 | 4,385,000 | |
| total current liabilities | 84,354,000 | 109,773,000 | 125,059,000 | 142,525,000 | 147,682,000 | 164,917,000 | 177,948,000 | 155,402,000 | 132,270,000 | 99,300,000 | 93,809,000 | 160,889,000 | 149,409,000 | 142,878,000 | 139,555,000 | 132,815,000 | 74,393,000 | 64,062,000 | 68,088,000 | 71,087,000 | 65,856,000 | 71,775,000 | 61,970,000 | 58,718,000 | 67,102,000 | 55,834,000 | 47,948,000 |
| deferred revenue, long-term portion | 168,870,000 | 170,308,000 | 172,169,000 | 192,775,000 | 199,583,000 | 204,575,000 | 210,845,000 | 229,848,000 | 245,343,000 | 431,079,000 | 443,370,000 | 386,357,000 | 413,899,000 | 505,133,000 | 334,415,000 | 344,529,000 | 96,208,000 | 105,493,000 | 108,417,000 | 110,560,000 | 110,321,000 | 114,141,000 | 123,236,000 | 129,875,000 | 121,227,000 | 130,489,000 | 139,715,000 |
| long-term debt | 9,536,000 | 9,464,000 | 9,389,000 | ||||||||||||||||||||||||
| refund liability to collaboration partner, long-term portion | 9,276,000 | 34,597,000 | 44,157,000 | 56,700,000 | 67,047,000 | 91,849,000 | 101,175,000 | ||||||||||||||||||||
| operating lease liabilities, long-term portion | 21,043,000 | 22,754,000 | 24,376,000 | 25,959,000 | 27,506,000 | 29,022,000 | 30,456,000 | 31,843,000 | 32,745,000 | 34,050,000 | 35,268,000 | 36,455,000 | 37,615,000 | 38,751,000 | 39,806,000 | 40,834,000 | 41,839,000 | 42,822,000 | 43,744,000 | 39,257,000 | 40,029,000 | 40,785,000 | 41,471,000 | 42,141,000 | 42,797,000 | 43,439,000 | |
| other long-term liabilities | 1,444,000 | 1,394,000 | 1,234,000 | 1,234,000 | 1,234,000 | 1,373,000 | 1,373,000 | 898,000 | 898,000 | 898,000 | 759,000 | 233,000 | 233,000 | 158,000 | 158,000 | 158,000 | 158,000 | 158,000 | 472,000 | 493,000 | 493,000 | 493,000 | 493,000 | 409,000 | 409,000 | 96,000 | 96,000 |
| total liabilities | 285,247,000 | 313,693,000 | 341,503,000 | 397,090,000 | 420,162,000 | 456,587,000 | 487,669,000 | 509,840,000 | 512,431,000 | 565,327,000 | 573,206,000 | 583,934,000 | 601,156,000 | 686,920,000 | 513,934,000 | 518,336,000 | 212,598,000 | 212,535,000 | 220,721,000 | 221,397,000 | 216,699,000 | 227,194,000 | 227,170,000 | 231,143,000 | 231,535,000 | 229,858,000 | 195,237,000 |
| commitments and contingencies | |||||||||||||||||||||||||||
| stockholders’ equity: | |||||||||||||||||||||||||||
| common stock | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 9,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 7,000 | 7,000 | 7,000 | 7,000 | 1,000 |
| additional paid-in capital | 971,192,000 | 964,008,000 | 955,657,000 | 945,046,000 | 936,011,000 | 925,458,000 | 844,044,000 | 831,912,000 | 821,853,000 | 810,750,000 | 798,696,000 | 787,097,000 | 775,843,000 | 762,458,000 | 748,036,000 | 726,692,000 | 701,670,000 | 689,630,000 | 676,956,000 | 666,958,000 | 658,642,000 | 648,783,000 | 414,414,000 | 407,647,000 | 402,823,000 | 399,066,000 | 17,078,000 |
| accumulated other comprehensive income | 96,000 | 191,000 | 261,000 | 931,000 | -620,000 | -403,000 | 184,000 | -943,000 | -41,000 | 203,000 | 410,000 | 614,000 | 1,094,000 | 1,846,000 | 2,782,000 | 142,000 | 226,000 | 441,000 | 108,000 | ||||||||
| accumulated deficit | -900,122,000 | -869,598,000 | -829,127,000 | -827,053,000 | -784,833,000 | -746,157,000 | -710,078,000 | -668,644,000 | -624,169,000 | -625,544,000 | -579,687,000 | -527,259,000 | -481,111,000 | -490,994,000 | -446,377,000 | -390,769,000 | -517,366,000 | -462,219,000 | -410,048,000 | -357,869,000 | -305,165,000 | -259,839,000 | -219,820,000 | -189,293,000 | -157,555,000 | -132,995,000 | -114,435,000 |
| total stockholders’ equity | 71,175,000 | 94,610,000 | 126,800,000 | 118,933,000 | 150,567,000 | 178,907,000 | 134,158,000 | 218,587,000 | 245,716,000 | 266,186,000 | |||||||||||||||||
| total liabilities and stockholders’ equity | 356,422,000 | 408,303,000 | 468,303,000 | 516,023,000 | 570,729,000 | 635,494,000 | 621,827,000 | 854,226,000 | 397,113,000 | 440,364,000 | 531,588,000 | 572,030,000 | 618,928,000 | ||||||||||||||
| receivable from collaboration partner | 10,465,000 | 7,825,000 | 4,699,000 | 2,587,000 | 6,491,000 | 8,816,000 | 12,819,000 | 7,391,000 | 1,584,000 | ||||||||||||||||||
| liabilities and stockholders' equity | |||||||||||||||||||||||||||
| stockholders' equity: | |||||||||||||||||||||||||||
| accumulated other comprehensive loss | -721,000 | -1,386,000 | -2,199,000 | -4,575,000 | -6,742,000 | -6,224,000 | -3,935,000 | -42,000 | |||||||||||||||||||
| total stockholders' equity | 162,555,000 | 196,306,000 | 183,015,000 | 214,442,000 | 253,104,000 | 288,516,000 | 267,537,000 | 300,724,000 | 335,890,000 | 184,515,000 | 227,829,000 | 267,530,000 | 310,191,000 | 355,331,000 | 391,734,000 | 194,743,000 | |||||||||||
| total liabilities and stockholders' equity | 672,395,000 | 708,737,000 | 748,342,000 | 787,648,000 | 837,038,000 | 889,672,000 | 954,457,000 | 814,658,000 | 488,251,000 | ||||||||||||||||||
| liabilities, convertible preferred stock, and stockholders' equity | |||||||||||||||||||||||||||
| deferred rent, current portion | 15,000 | ||||||||||||||||||||||||||
| deferred rent, long-term portion | 7,478,000 | ||||||||||||||||||||||||||
| convertible preferred stock; 0.0001 par value; zero and 45,849,677 shares authorized as of december 31, 2019 and 2018, respectively; zero and 45,374,836 shares issued and outstanding as of december 31, 2019 and 2018, respectively | |||||||||||||||||||||||||||
| stockholders' equity | |||||||||||||||||||||||||||
| total liabilities, convertible preferred stock, and stockholders' equity | 421,913,000 | ||||||||||||||||||||||||||
| liabilities, convertible preferred stock, and stockholders’ equity | |||||||||||||||||||||||||||
| convertible preferred stock; 0.0001 par value; zero and 45,849,677 shares authorized as of september 30, 2019 and december 31, 2018, respectively; zero and 45,374,836 shares issued and outstanding as of september 30, 2019 and december 31, 2018, respectively | |||||||||||||||||||||||||||
| stockholders’ equity | |||||||||||||||||||||||||||
| total liabilities, convertible preferred stock, and stockholders’ equity | 449,730,000 | 477,251,000 | 496,044,000 | ||||||||||||||||||||||||
| convertible preferred stock; 0.0001 par value; zero and 45,849,677 shares authorized as of june 30, 2019 and december 31, 2018, respectively; zero and 45,374,836 shares issued and outstanding as of june 30, 2019 and december 31, 2018, respectively | |||||||||||||||||||||||||||
| convertible preferred stock; 0.0001 par value; zero and 45,849,677 shares authorized as of march 31, 2019 and december 31, 2018, respectively; zero and 45,374,836 shares issued and outstanding as of march 31, 2019 and december 31, 2018, respectively | |||||||||||||||||||||||||||
| accounts receivable | |||||||||||||||||||||||||||
| liabilities, convertible preferred stock, and stockholders’ deficit | |||||||||||||||||||||||||||
| convertible preferred stock; 0.0001 par value; 45,849,677 and 36,001,203 shares authorized as of december 31, 2018 and 2017, respectively; 45,374,836 and 36,001,203 shares issued and outstanding as of december 31, 2018 and 2017, respectively; liquidation preference of 211,054 as of december 31, 2018 | 210,520,000 | ||||||||||||||||||||||||||
| stockholders’ deficit: | |||||||||||||||||||||||||||
| total stockholders’ deficit | -97,398,000 | ||||||||||||||||||||||||||
| total liabilities, convertible preferred stock, and stockholders’ deficit | 308,359,000 | ||||||||||||||||||||||||||
| revenue: | |||||||||||||||||||||||||||
| collaboration revenue | 27,508,000 | ||||||||||||||||||||||||||
| grant revenue | 169,000 | ||||||||||||||||||||||||||
| total revenue | 27,677,000 | ||||||||||||||||||||||||||
| operating expenses: | |||||||||||||||||||||||||||
| research and development | 73,031,000 | ||||||||||||||||||||||||||
| general and administrative | 11,934,000 | ||||||||||||||||||||||||||
| total operating expenses | 84,965,000 | ||||||||||||||||||||||||||
| income from operations | -57,288,000 | ||||||||||||||||||||||||||
| other income | 5,040,000 | ||||||||||||||||||||||||||
| net income | -52,248,000 | ||||||||||||||||||||||||||
| unrealized loss on marketable securities | -42,000 | ||||||||||||||||||||||||||
| comprehensive loss | -52,290,000 | ||||||||||||||||||||||||||
| net income per share | -4,620 | ||||||||||||||||||||||||||
| shares used in computing net income per share, basic and diluted | 11,302,788,000 |
We provide you with 20 years of balance sheets for Alector stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Alector. Explore the full financial landscape of Alector stock with our expertly curated balance sheets.
The information provided in this report about Alector stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.